QuartataWeb 1.0

13 known interactions (drugs) of input target (ABO): Histo-blood group ABO system transferase

No.	Group	Type	Drug ID	Drug Name	SMILES ⇨ TargetHunter
1	Experimental	SmallMoleculeDrug	DB04678	H TYPE II TRISACCHARIDE	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@H]2[C@H](O)[C@@H](NC(C)=O)[C@H](O)O[C@@H]2CO)[C@@H](O)[C@H](O)[C@@H]1O
2	Experimental	SmallMoleculeDrug	DB07341	octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside	[H][C@]1(O)C[C@]([H])(O[C@]2([H])[C@@]([H])(N)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]2([H])OCCCCCCCC)O[C@@]([H])(C)[C@@]1([H])O
3	Experimental	SmallMoleculeDrug	DB02196	Uridine-Diphosphate-N-Acetylgalactosamine	CC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
4	Experimental	SmallMoleculeDrug	DB04141	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
5	Experimental	SmallMoleculeDrug	DB03501	Galactose-uridine-5'-diphosphate	OC[C@H]1O[C@H](O[P@@](O)(=O)O[P@@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@H]1O
6	Experimental	SmallMoleculeDrug	DB07378	4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL	[H][C@]1(N)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCCCC)[C@]1([H])O
7	Experimental	SmallMoleculeDrug	DB04680	GALACTOSE GREASE	[H][C@]1(O)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCCCCC(=O)OC)[C@]1([H])O
8	Experimental	SmallMoleculeDrug	DB04681	BETA-METHYLLACTOSIDE	CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
9	Experimental	SmallMoleculeDrug	DB04679	H TYPE I TRISACCHARIDE	[H][C@@]1(C)O[C@@]([H])(O[C@@]2([H])[C@]([H])(O[C@@]3([H])[C@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(O)[C@]3([H])N=C(C)O)O[C@]([H])(CO)[C@]([H])(O)[C@]2([H])O)[C@@]([H])(O)[C@]([H])(O)[C@]1([H])O
10	Experimental	SmallMoleculeDrug	DB03772	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol	[H][C@@]1(O)C[C@@]([H])(O)[C@]([H])(OCCCCCC)O[C@]1([H])CO
11	Experimental	SmallMoleculeDrug	DB07633	octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside	[H][C@@]1(O)C[C@@]([H])(O[C@]2([H])O[C@@]([H])(C)[C@@]([H])(O)[C@@]([H])(O)[C@]2([H])O)[C@]([H])(OCCCCCCCC)O[C@]1([H])CO
12	Experimental	SmallMoleculeDrug	DB07357	4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL	[H][C@]1(N)[C@@]([H])(O)[C@@]([H])(CO)O[C@@]([H])(OCCCCCC)[C@]1([H])O
13	Experimental	SmallMoleculeDrug	DB03435	Uridine-5'-Diphosphate	O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O

20 predicted interactions (drugs) of input target (ABO): Histo-blood group ABO system transferase

No.	Group	Type	Drug ID	Drug Name	SMILES ⇨ TargetHunter	Confidence score
1	Approved; Nutraceutical	SmallMoleculeDrug	DB00126	Vitamin C	[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO	39.7%
2	Experimental	SmallMoleculeDrug	DB03397	Uridine-Diphosphate-N-Acetylglucosamine	CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O	36.5%
3	Experimental	SmallMoleculeDrug	DB01861	Uridine diphosphate glucose	OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@H](O)[C@@H](O)[C@@H]1O	33.3%
4	Approved	SmallMoleculeDrug	DB01250	Olsalazine	OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(O)C(=C1)C(O)=O	26.2%
5	Approved; Vet approved	SmallMoleculeDrug	DB08818	Hyaluronic acid	CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O	24.1%
6	Approved; Investigational	SmallMoleculeDrug	DB01103	Quinacrine	CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=C1C=CC(Cl)=C2	23.9%
7	Approved; Nutraceutical	SmallMoleculeDrug	DB00156	L-Threonine	C[C@@H](O)[C@H](N)C(O)=O	23.7%
8	Experimental	SmallMoleculeDrug	DB07763	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(F)C=C1F	23.6%
9	Approved; Investigational	SmallMoleculeDrug	DB11638	Artenimol	[H][C@@]1(C)CC[C@@]2([H])[C@@]([H])(C)C([H])(O)O[C@]3([H])O[C@@]4(C)CC[C@]1([H])[C@@]23OO4	23.3%
10	Approved; Nutraceutical	SmallMoleculeDrug	DB00133	Serine	N[C@@H](CO)C(O)=O	23.3%
11	Approved; Investigational	SmallMoleculeDrug	DB09130	Copper	[Cu]	23.0%
12	Experimental	SmallMoleculeDrug	DB03095	Tetramethylammonium Ion	C[N+](C)(C)C	22.1%
13	Approved; Nutraceutical	SmallMoleculeDrug	DB00149	L-Leucine	CC(C)C[C@H](N)C(O)=O	22.0%
14	Approved; Withdrawn	SmallMoleculeDrug	DB09092	Xanthinol	CN(CCO)CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C	21.9%
15	Approved; Experimental	SmallMoleculeDrug	DB03017	Lauric Acid	CCCCCCCCCCCC(O)=O	20.8%
16	Experimental	SmallMoleculeDrug	DB01782	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	O=C1C2=CC=CC3=C2C(=NN3)C2=C1C=CC=C2	20.6%
17	Nutraceutical	SmallMoleculeDrug	DB00116	Tetrahydrofolic acid	NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)N1	20.4%
18	Experimental	SmallMoleculeDrug	DB07778	FAMOXADONE	C[C@]1(OC(=O)N(NC2=CC=CC=C2)C1=O)C1=CC=C(OC2=CC=CC=C2)C=C1	20.2%
19	Experimental	SmallMoleculeDrug	DB03467	Naringenin	[H][C@]1(CC(=O)C2=C(O1)C=C(O)C=C2O)C1=CC=C(O)C=C1	20.2%
20	Approved; Investigational; Vet approved; Withdrawn	SmallMoleculeDrug	DB01108	Trilostane	[H][C@]12O[C@]11CC[C@@]3([H])[C@]4([H])CC[C@H](O)[C@@]4(C)CC[C@]3([H])[C@@]1(C)CC(C#N)=C2O	19.6%